Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (32)

« Back to Publications

Ascertainment of delirium in older adults presenting to a primary care out of hours (OOH) service: a retrospective cohort study

Seeley A. et al, (2026), AGE AND AGEING, 55

Efficacy and safety of statin discontinuation in older people living with frailty: a UK population-wide study

Seeley A. et al, (2026), AGE AND AGEING, 55

Agreement and utility of coded primary and secondary care data for long-term follow-up of clinical trial outcomes

Wang A. et al, (2025), BMC Medical Research Methodology, 25

Predicting hypotension, syncope, and fracture risk in patients indicated for antihypertensive treatment: the STRATIFY models

Koshiaris C. et al, (2025), Nature Communications, 16

Associations between falls and other serious adverse events and antihypertensive medication in individuals with dementia: An observational cohort study

Fujiwara T. et al, (2025), Plos Medicine, 22

Implementation, Processes and Outcomes of Advance Care Planning: A Culturally and Contextually Appropriate Programme Theory Developed in Chinese Long-Term Care Facilities

Zhou Y. et al, (2025), Health Expectations, 28

Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations

Wang A. et al, (2025), Journal of Hypertension

Risk Stratification in Older Intensively Treated Patients With AML

Versluis J. et al, (2024), Journal of Clinical Oncology, 42, 4084 - 4094

Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial

Sheppard JP. et al, (2024), The Lancet Healthy Longevity, 5, e563 - e573

Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial

SHEPPARD J. et al, (2024), The Lancet Healthy Longevity

What are the barriers and facilitators to advance care planning with older people in long-term care facilities? A qualitative study

Zhou Y. et al, (2024), Journal of Clinical Nursing

Associations between falls and other serious adverse events and antihypertensive medication in individuals with dementia: An observational cohort study

Fujiwara T. et al, (2024), CIRCULATION, 150

EFFECT OF ANTIHYPERTENSIVE DEPRESCRIBING ON SERIOUS ADVERSE EVENTS, MORTALITY, AND CARDIOVASCULAR DISEASE: LONG-TERM FOLLOW-UP OF THE OPTIMISE RANDOMISED CONTROLLED TRIAL

Sheppard J. et al, (2024), JOURNAL OF HYPERTENSION, 42

Patients views on a new surveillance pathway involving allied non-medical staff for people with treated diabetic macular oedema and proliferative diabetic retinopathy

Prior L. et al, (2023), Eye (Basingstoke), 37, 1155 - 1159

PREDITING THE RISK OF FRACTURE ASSOCIATED WITH ANTIHYPERTENSIVE TREATMENT: DEVELOPMENT OF THE STRATIFY-FRACTURE PREDICTION MODEL

Wang A. et al, (2023), JOURNAL OF HUMAN HYPERTENSION, 37, 11 - 11

Load More